Sign in

CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471144582
Phone
781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,050,832
in 7 filings, $404K under 10b5-1 plans

Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ticho Barry −$540K CHIEF MEDICAL OFFICER sold 61% of stake
  2. Kaye Edward M. MD −$403K Director sold 9% of stake
  3. Allan Jonathan −$108K GENERAL COUNSEL & CORP SEC sold 14% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-16 Allan Jonathan GENERAL COUNSEL & CORP SEC Sale 10b5-1 −1,457 $29.95 $44K 18,086
2026-06-03 Krainer Adrian R. Director Grant or award · Director Stock Option (Right to Buy) +17,786 17,786
2026-06-03 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +17,786 17,786
2026-06-03 TZIANABOS ARTHUR Director Grant or award · Director Stock Option (Right to Buy) +17,786 17,786
2026-06-03 Smith Julie Director Grant or award · Director Stock Option (Right to Buy) +17,786 17,786
2026-06-03 Kaye Edward M. MD Director Grant or award · Director Stock Option (Right to Buy) +17,786 17,786
2026-06-03 Harrison Seth Loring Director Grant or award · Director Stock Option (Right to Buy) +17,786 17,786
2026-06-03 LEVIN ARTHUR A Director Grant or award · Director Stock Option (Right to Buy) +17,786 17,786
2026-06-01 Ticho Barry CHIEF MEDICAL OFFICER Sale 10b5-1 −1,795 $30.58 $55K 34,826
2026-05-01 Ticho Barry CHIEF MEDICAL OFFICER Sale 10b5-1 −2,243 $32.79 $74K 36,621
2026-04-03 Kahn Clare Director Grant or award · Stock Option (Right to Buy) +30,782 30,782
2026-04-01 Ticho Barry CHIEF MEDICAL OFFICER Sale 10b5-1 −1,838 $32.66 $60K 38,864
2026-03-20 Allan Jonathan GENERAL COUNSEL & CORP SEC Sale 10b5-1 −8,692 $33.64 $292K 20,144
2026-03-20 Allan Jonathan GENERAL COUNSEL & CORP SEC Sale 10b5-1 −601 $34.41 $21K 19,543
2026-03-19 Ticho Barry CHIEF MEDICAL OFFICER Option exercise 10b5-1 +1,365 $2.19 $3K 42,163
2026-03-19 Ticho Barry CHIEF MEDICAL OFFICER Sale 10b5-1 −1,461 $29.99 $44K 40,702
2026-03-19 Ticho Barry CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −1,365 83,035
2026-03-18 Allan Jonathan GENERAL COUNSEL & CORP SEC Sale −4,222 $31.28 $132K 29,242
2026-03-18 Allan Jonathan GENERAL COUNSEL & CORP SEC Sale −334 $31.79 $11K 28,908
2026-03-18 Allan Jonathan GENERAL COUNSEL & CORP SEC Sale −72 $32.85 $2K 28,836

Page 3 of 13 · 256 trades